People who get even a small amount of exercise may be less likely to die prematurely than their more sedentary counterparts, a research review suggests.
Older adults who cut back on the amount of vegetable protein in their diets may be more likely to experience age-related health problems than their peers who increase the amount of plant protein they eat, a Spanish study suggests.
Hearing loss in middle age is associated with higher odds of cognitive decline and dementia in later years, suggests a large study in Taiwan.
With a goal of eradicating hepatitis C, NHS England has teamed up Gilead Sciences Inc., Merck & Co. and AbbVie Inc.
There has been a heightened interest in longevity research. Some have noted that older billionaires such as Bill Gates, Michael Bloomberg, Richard Branson and others have been investing heavily into biopharma companies focused on aging and aging-related diseases.
Gilead Sciences Launches Age Positively Initiative to Address Unique Challenges of Aging Population Living with HIV
Gilead Sciences Inc. announced that the company is providing $17.6 million in grants to 30 organizations in the United States through the Gilead HIV Age Positively initiative.
The online publication NEO.LIFE pointed to seven areas where biotech companies and researchers have significant potential to “dramatically reshape our concept of what it means to be human.”
Two leading longevity biotechnology companies, Elevian and Insilico Medicine, announced a research and development partnership to develop oral medications targeting the GDF11 pathway and associated targets.
Cancer will claim the lives of 9.6 million people in 2018, accounting for one in eight of all deaths among men and one in 11 among women, the WHO’s cancer research agency said.
In another example of companies focused on aging-related diseases, Elevian launched with $5.5 million in seed funding.